Description

Graphical summary of clinical outcome measures used to evaluate cognitive function in trials of antioxidant interventions, including MMSE scores, ADAS-Cog assessments, and neuroimaging parameters.

Figure 16

Chart

Source Paper

Mitochondria- and Oxidative Stress-Targeting Substances in Cognitive Decline-Related Disorders: From Molecular Mechanisms to Clinical Evidence.

Oxidative medicine and cellular longevity (2019)

PMID: 31214285

DOI: 10.1155/2019/9695412

Cite This Figure

![Figure 16: Graphical summary of clinical outcome measures used to evaluate cognitive function in trials of antioxidant interventions, including MMSE scores, ADAS-Cog assessments, and neuroimaging parameters.]()

> Source: Imane Lejri et al. "Mitochondria- and Oxidative Stress-Targeting Substances in Cognitive Decline-Rel." *Oxidative medicine and cellular longevity*, 2019. PMID: [31214285](https://pubmed.ncbi.nlm.nih.gov/31214285/)

<figure>
  <img src="" alt="Graphical summary of clinical outcome measures used to evaluate cognitive function in trials of antioxidant interventions, including MMSE scores, ADAS-Cog assessments, and neuroimaging parameters." />
  <figcaption>Figure 16. Graphical summary of clinical outcome measures used to evaluate cognitive function in trials of antioxidant interventions, including MMSE scores, ADAS-Cog assessments, and neuroimaging parameters.<br>  Source: Imane Lejri et al. "Mitochondria- and Oxidative Stress-Targeting Substances in Cognitive Decline-Rel." <em>Oxidative medicine and cellular longevity</em>, 2019. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/31214285/">31214285</a></figcaption>
</figure>

Preuves associées

Ginkgo biloba pour Age-Related Cognitive Decline

Note C · 40 études